ImmunoPrecise Antibodies Ltd (NASDAQ:IPA) concluded the trading at $1.11 on Thursday, June 26 with a rise of 19.06% from its closing price on previous day.
Taking a look at stock we notice that its last check on previous day was $0.93 and 5Y monthly beta was reading 0.216 with its price kept floating in the range of $0.93 and $1.08 on the day. Considering stock’s 52-week price range provides that IPA hit a high price of $1.07 and saw its price falling to a low level of $0.27 during that period. Over a period of past 1-month, stock came adding 107.87% in its value.
In contrast, when we review IPA stock’s current outlook then short term indicators are assigning it an average of 100% Buy, while medium term indicators are categorizing the stock at an average of 100% Buy. Long term indicators are suggesting an average of 50% Buy for it.
Digging deeper we become aware of the PEG ratio of the IPA stock which is currently positioned at 0. It further provides that stock’s current price level is 44.75% away from its 20-day simple moving average and is 88.70% off its SMA50. Its relative strength index (RSI) for 14-periods is oscillating at 78.38 while volatility remained at 15.02% over the past week which changes to 15.47% when measuring it over the past month. Beta is valued at 0.31.
Having a second look at ImmunoPrecise Antibodies Ltd (NASDAQ:IPA) provides that stock’s average daily trading volume for 3 months was 1.77 million, while it jumped to 8761440 when we calculate an average volume for past 10 days. Number of outstanding shares of the stock stood at 45.77 million.
The percentage of outstanding shares held by the insiders is 13.30% while it is 8.65% for the institutional holders. The figures also indicate that as of 2025-06-13, number of stock’s short shares was 1.39 million which implies a short ratio of 0.38. This shows up a 306.00 of Short Interest in company’s outstanding shares on the day. In June the standing of shares short improved as it was 0.16 million in the previous month. Addition of 12.05% by stock’s current price to its year-to-date value in last trading session is likely to be increasing investors’ interest in the stock as it is hinting an extended uptrend.
